Literature DB >> 15045182

[Psychosomatic aspects of the chronic pelvic pain syndrome].

H J Berberich1, M Ludwig.   

Abstract

Epidemiologic data have demonstrated the significance of chronic prostatitis/chronic pelvic pain syndrome (CP/CPSS) for the urological practice. Apart from the rare cases of bacterial prostatitis numerous somatic models have failed to completely explain pathogenetic interrelations; therapeutic attempts frequently have produced unsatisfactory results. Additionally, psychosomatic factors have often been neglected. A number of personality variables have turned out to play an important role in questionnaire-based studies, namely somatization and depression, as well as anxiety, hypochondriasis, and weak masculine identity. However, these preliminary results need further evaluation. In the future, diagnostic and therapeutic strategies should pay attention to the complex interweavement of somatic and psychogenic factors in the pathogenesis of CP/CPSS.

Entities:  

Mesh:

Year:  2004        PMID: 15045182     DOI: 10.1007/s00120-003-0511-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

1.  Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option.

Authors:  S A Kaplan; R P Santarosa; P M D'Alisera; B J Fay; E F Ikeguchi; J Hendricks; L Klein; A E Te
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

2.  Few patients with "chronic prostatitis" have significant bladder outlet obstruction.

Authors:  M E Mayo; S O Ross; J N Krieger
Journal:  Urology       Date:  1998-09       Impact factor: 2.649

3.  Prevalence of chronic prostatitis in men with premature ejaculation.

Authors:  E Screponi; E Carosa; S M Di Stasi; M Pepe; G Carruba; E A Jannini
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

4.  Psychological and physical factors involved in chronic idiopathic prostatitis.

Authors:  J P Berghuis; J R Heiman; I Rothman; R E Berger
Journal:  J Psychosom Res       Date:  1996-10       Impact factor: 3.006

5.  How common is prostatitis? A national survey of physician visits.

Authors:  M M Collins; R S Stafford; M P O'Leary; M J Barry
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

6.  Psychic disturbances in patients with chronic prostatis.

Authors:  L Keltikangas-Järvinen; H Järvinen; T Lehtonen
Journal:  Ann Clin Res       Date:  1981-02

Review 7.  Etiology: where does prostatitis stop and interstitial cystitis begin?

Authors:  Evan R Eisenberg; Robert M Moldwin
Journal:  World J Urol       Date:  2003-05-28       Impact factor: 4.226

8.  Diagnosis and treatment of 409 patients with prostatitis syndromes.

Authors:  J J de la Rosette; M R Hubregtse; E J Meuleman; M V Stolk-Engelaar; F M Debruyne
Journal:  Urology       Date:  1993-04       Impact factor: 2.649

Review 9.  Chronic pelvic pain syndrome: a non-prostatocentric perspective.

Authors:  Jeannette M Potts
Journal:  World J Urol       Date:  2003-04-04       Impact factor: 4.226

10.  Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy.

Authors:  Petr Hruz; Hansjörg Danuser; Urs E Studer; Werner W Hochreiter
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

View more
  4 in total

Review 1.  [Chronic pelvic pain].

Authors:  O Moormann; I Gralow
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

2.  [Psychosomatic urology. A practice-oriented presentation].

Authors:  M Schwinges-Lymberopoulos
Journal:  Urologe A       Date:  2010-06       Impact factor: 0.639

3.  [Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment - a randomized controlled study].

Authors:  S Marx; U Cimniak; R Beckert; F Schwerla; K L Resch
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

4.  [Long-term effects of osteopathic treatment of chronic prostatitis with chronic pelvic pain syndrome: a 5-year follow-up of a randomized controlled trial and considerations on the pathophysiological context].

Authors:  S Marx; U Cimniak; M Rütz; K L Resch
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.